(Q34581085)

English

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial (English)

1 reference

Europe PubMed Central

3 August 2017

phase III clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Miriam Koopman

1

1 reference

Europe PubMed Central

3 August 2017

Ninja F Antonini

2

1 reference

Europe PubMed Central

3 August 2017

Joep Douma

3

1 reference

Europe PubMed Central

3 August 2017

Jaap Wals

4

1 reference

Europe PubMed Central

3 August 2017

Aafke H Honkoop

5

1 reference

Europe PubMed Central

3 August 2017

Frans L G Erdkamp

6

1 reference

Europe PubMed Central

3 August 2017

Robert S de Jong

7

1 reference

Europe PubMed Central

3 August 2017

Cees J Rodenburg

8

1 reference

Europe PubMed Central

3 August 2017

Gerard Vreugdenhil

9

1 reference

Europe PubMed Central

3 August 2017

Olaf J L Loosveld

10

1 reference

Europe PubMed Central

3 August 2017

Aart van Bochove

11

1 reference

Europe PubMed Central

3 August 2017

Harm A M Sinnige

12

1 reference

Europe PubMed Central

3 August 2017

Geert-Jan M Creemers

13

1 reference

Europe PubMed Central

3 August 2017

Margot E T Tesselaar

14

1 reference

Europe PubMed Central

3 August 2017

Peter H Th J Slee

15

1 reference

Europe PubMed Central

3 August 2017

Marjon J B P Werter

16

1 reference

Europe PubMed Central

3 August 2017

Linda Mol

17

1 reference

Europe PubMed Central

3 August 2017

Otilia Dalesio

18

1 reference

Europe PubMed Central

3 August 2017

Cornelis J A Punt

19

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

370

1 reference

Europe PubMed Central

3 August 2017

135-142

1 reference

Europe PubMed Central

3 August 2017

9582

1 reference

Europe PubMed Central

3 August 2017

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New options and old dilemmas in the treatment of patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961086-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61086-1

1 reference

Europe PubMed Central

3 August 2017

release_kccny64hbbarxlub3jzm5tgobu

1 reference

https://api.fatcat.wiki/v0/release/kccny64hbbarxlub3jzm5tgobu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34581085&oldid=1988024641"